Biju Parekkadan - Publications

Affiliations: 
2002-2008 HST MIT, Harvard Medical School 

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Doshi A, Erickson P, Teryek M, Parekkadan B. Dynamics of Ex Vivo Mesenchymal Stromal Cell Potency under Continuous Perfusion. International Journal of Molecular Sciences. 24. PMID 37298556 DOI: 10.3390/ijms24119602  0.368
2023 Teryek M, Jadhav P, Bento R, Parekkadan B. 3D Microcapsules for Human Bone Marrow Derived Mesenchymal Stem Cell Biomanufacturing in a Vertical-Wheel Bioreactor. Biorxiv : the Preprint Server For Biology. PMID 36824906 DOI: 10.1101/2023.02.16.528656  0.358
2021 Swaminathan M, Kopyt N, Atta MG, Radhakrishnan J, Umanath K, Nguyen S, O'Rourke B, Allen A, Vaninov N, Tilles A, LaPointe E, Blair A, Gemmiti C, Miller B, Parekkadan B, et al. Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation. Stem Cells Translational Medicine. PMID 34581517 DOI: 10.1002/sctm.21-0043  0.358
2021 O'Rourke B, Nguyen S, Tilles AW, Bynum JA, Cap AP, Parekkadan B, Barcia RN. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. Stem Cells Translational Medicine. PMID 33527780 DOI: 10.1002/sctm.20-0454  0.342
2020 Allen A, Vaninov N, Li M, Nguyen S, Singh M, Igo P, Tilles AW, O'Rourke B, Miller BLK, Parekkadan B, Barcia RN. Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells. Scientific Reports. 10: 15451. PMID 32943743 DOI: 10.1038/S41598-020-72947-Y  0.39
2020 Tamayo AG, Shukor S, Burr A, Erickson P, Parekkadan B. Tracking leukemic T-cell transcriptional Dynamics in vivo with a blood-based reporter assay. Febs Open Bio. PMID 32710494 DOI: 10.1002/2211-5463.12940  0.414
2020 Allen A, Vaninov N, Li M, Nguyen S, Igo P, Tilles AW, O'Rourke B, Miller BLK, Parekkadan B, Barcia RN. Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells. Scientific Reports. 10: 10142. PMID 32576889 DOI: 10.1038/S41598-020-67039-W  0.449
2020 Barcia R, Nguyen S, O'Rourke B, Igo P, Tilles A, Miller B, Parekkadan B. Immune Reprogramming in Human Subjects after Extracorporeal Mesenchymal Stromal Cell Therapy Cytotherapy. 22: S11. DOI: 10.1016/J.Jcyt.2020.03.473  0.436
2019 Aijaz A, Trawinski D, McKirgan S, Parekkadan B. Non-invasive cell counting of adherent, suspended and encapsulated mammalian cells using optical density. Biotechniques. PMID 31870165 DOI: 10.2144/Btn-2019-0052  0.396
2019 Chin LY, Carroll C, Raigani S, Detelich DM, Tessier SN, Wojtkiewicz GR, Schmidt SP, Weissleder R, Yeh H, Uygun K, Parekkadan B. Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs. Plos One. 14: e0225222. PMID 31790444 DOI: 10.1371/Journal.Pone.0225222  0.4
2019 Timmins LM, Patel RS, Teryek MS, Parekkadan B. Real-time transfer of lentiviral particles by producer cells using an engineered coculture system. Cytotechnology. PMID 31515650 DOI: 10.1007/S10616-019-00343-0  0.367
2019 Burr A, Parekkadan B. Kinetics of MSC-based enzyme therapy for immunoregulation. Journal of Translational Medicine. 17: 263. PMID 31409424 DOI: 10.1186/S12967-019-2000-6  0.402
2019 Li M, Chin LY, Shukor S, Tamayo AG, Maus MV, Parekkadan B. Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression. Autoimmunity. 1-6. PMID 31238751 DOI: 10.1080/08916934.2019.1630064  0.351
2019 Aijaz A, Vaninov N, Allen A, Barcia RN, Parekkadan B. Convergence of Cell Pharmacology and Drug Delivery. Stem Cells Translational Medicine. PMID 31091020 DOI: 10.1002/Sctm.19-0019  0.407
2019 Barcia R, Allen A, Vaninov N, Nguyen S, Goodale L, Igo P, Tilles A, Huertas P, Miller B, Parekkadan B. PhaseI/II interim analysis of extracorporeal mesenchymal Stromal cell therapy (SBI-101 Therapy) in subjects with acute kidney injury Cytotherapy. 21: e5. DOI: 10.1016/J.Jcyt.2019.04.016  0.411
2019 Allen A, Vaninov N, Nguyen S, Igo P, Tilles A, Parekkadan B, Barcia R. Restoring balance to the immune system via Ex Vivo MSC therapy Cytotherapy. 21: S56. DOI: 10.1016/J.Jcyt.2019.03.428  0.481
2018 Aijaz A, Li M, Smith D, Khong D, LeBlon C, Fenton OS, Olabisi RM, Libutti S, Tischfield J, Maus MV, Deans R, Barcia RN, Anderson DG, Ritz J, Preti R, ... Parekkadan B, et al. Biomanufacturing for clinically advanced cell therapies. Nature Biomedical Engineering. 2: 362-376. PMID 31011198 DOI: 10.1038/S41551-018-0246-6  0.423
2018 Li M, Chin LY, Shukor S, Tamayo A, Maus MV, Parekkadan B. Closed loop bioreactor system for the ex vivo expansion of human T cells. Cytotherapy. PMID 30497956 DOI: 10.1016/J.Jcyt.2018.10.009  0.353
2018 Mukundan S, Sharma K, Honselmann K, Singleton A, Liss A, Parekkadan B. Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model. Technology in Cancer Research & Treatment. 17: 1533033818803632. PMID 30348057 DOI: 10.1177/1533033818803632  0.337
2018 Miller BLK, Garg P, Bronstein B, LaPointe E, Lin H, Charytan DM, Tilles AW, Parekkadan B. Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury. Kidney International Reports. 3: 1119-1127. PMID 30197978 DOI: 10.1016/J.Ekir.2018.05.009  0.381
2018 Knoblich K, Cruz Migoni S, Siew SM, Jinks E, Kaul B, Jeffery HC, Baker AT, Suliman M, Vrzalikova K, Mehenna H, Murray PG, Barone F, Oo YH, Newsome PN, Hirschfield G, ... ... Parekkadan B, et al. The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation. Plos Biology. 16: e2005046. PMID 30180168 DOI: 10.1371/Journal.Pbio.2005046  0.381
2018 Li M, Khong D, Chin LY, Singleton A, Parekkadan B. Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction. Scientific Reports. 8: 6816. PMID 29717209 DOI: 10.1038/S41598-018-24971-2  0.451
2018 Khong D, Li M, Singleton A, Chin LY, Parekkadan B. Stromalized microreactor supports murine hematopoietic progenitor enrichment. Biomedical Microdevices. 20: 13. PMID 29353324 DOI: 10.1007/S10544-017-0255-3  0.399
2017 Khong D, Li M, Singleton A, Chin LY, Munkundan S, Parekkadan B. Orthogonal Potency Analysis of Mesenchymal Stromal Cell Function During Ex Vivo Expansion. Experimental Cell Research. PMID 29137914 DOI: 10.1016/J.Yexcr.2017.11.007  0.469
2017 Singleton A, Khong D, Chin LY, Mukundan S, Li M, Parekkadan B. An engineered biomarker system to monitor and modulate immune clearance of cell therapies. Cytotherapy. PMID 28917628 DOI: 10.1016/J.Jcyt.2017.08.003  0.407
2016 Lee J, Heckl D, Parekkadan B. Multiple genetically engineered humanized microenvironments in a single mouse. Biomaterials Research. 20: 19. PMID 27354920 DOI: 10.1186/S40824-016-0066-2  0.401
2016 Shen K, Luk S, Elman J, Murray R, Mukundan S, Parekkadan B. Suicide Gene-Engineered Stromal Cells Reveal a Dynamic Regulation of Cancer Metastasis. Scientific Reports. 6: 21239. PMID 26893143 DOI: 10.1038/Srep21239  0.34
2016 Parekkadan B. A wealth of cells Science Translational Medicine. 8: 323ec14-323ec14. DOI: 10.1126/Scitranslmed.Aaf0866  0.46
2015 Parekkadan B. Press pause to fast forward Science Translational Medicine. 7: 317ec211-317ec211. DOI: 10.1126/Scitranslmed.Aad8030  0.383
2015 Parekkadan B. Shining a light on stem cell biology Science Translational Medicine. 7: 299ec133-299ec133. DOI: 10.1126/Scitranslmed.Aac9320  0.358
2015 Parekkadan B. It takes two to tango Science Translational Medicine. 7: 287ec77-287ec77. DOI: 10.1126/Scitranslmed.Aab3976  0.337
2015 Parekkadan B. 256. Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by a Cell Therapeutic Molecular Therapy. 23: S100-S101. DOI: 10.1016/S1525-0016(16)33861-8  0.513
2014 Shen K, Luk S, Hicks DF, Elman JS, Bohr S, Iwamoto Y, Murray R, Pena K, Wang F, Seker E, Weissleder R, Yarmush ML, Toner M, Sgroi D, Parekkadan B. Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays. Nature Communications. 5: 5662. PMID 25489927 DOI: 10.1038/Ncomms6662  0.478
2014 Bersani F, Lee J, Yu M, Morris R, Desai R, Ramaswamy S, Toner M, Haber DA, Parekkadan B. Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models. Cancer Research. 74: 7229-38. PMID 25339351 DOI: 10.1158/0008-5472.Can-14-1809  0.407
2014 Fletcher AL, Elman JS, Astarita J, Murray R, Saeidi N, D'Rozario J, Knoblich K, Brown FD, Schildberg FA, Nieves JM, Heng TS, Boyd RL, Turley SJ, Parekkadan B. Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis. Science Translational Medicine. 6: 249ra109. PMID 25122637 DOI: 10.1126/Scitranslmed.3009377  0.396
2014 Shen K, Lee J, Yarmush ML, Parekkadan B. Microcavity substrates casted from self-assembled microsphere monolayers for spheroid cell culture. Biomedical Microdevices. 16: 609-15. PMID 24781882 DOI: 10.1007/S10544-014-9863-3  0.493
2014 Elman JS, Murray RC, Murray RM, Wang F, Shen K, Gao S, Conway KE, Yarmush ML, Tannous BA, Weissleder R, Parekkadan B. Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells. Plos One. 9: e89882. PMID 24587097 DOI: 10.1371/Journal.Pone.0089882  0.627
2014 Milwid JM, Elman JS, Li M, Shen K, Manrai A, Gabow A, Yarmush J, Jiao Y, Fletcher A, Lee J, Cima MJ, Yarmush ML, Parekkadan B. Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 999-1007. PMID 24496384 DOI: 10.1038/Mt.2014.17  0.772
2014 Elman JS, Li M, Wang F, Gimble JM, Parekkadan B. A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation. Journal of Inflammation (London, England). 11: 1. PMID 24397734 DOI: 10.1186/1476-9255-11-1  0.499
2014 Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Velle A, Li M, Vitalo A, Parekkadan B, Jindal R, Yarmush ML. Erratum: Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure Nature Biotechnology. 32: 291-291. DOI: 10.1038/nbt0314-291c  0.715
2013 Lee J, Wang JB, Bersani F, Parekkadan B. Capture and printing of fixed stromal cell membranes for bioactive display on PDMS surfaces. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 10611-6. PMID 23927769 DOI: 10.1021/La4012795  0.339
2012 Milwid JM, Ichimura T, Li M, Jiao Y, Lee J, Yarmush JS, Parekkadan B, Tilles AW, Bonventre JV, Yarmush ML. Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury. Stem Cells International. 2012: 392050. PMID 23319959 DOI: 10.1155/2012/392050  0.775
2012 Lee J, Li M, Milwid J, Dunham J, Vinegoni C, Gorbatov R, Iwamoto Y, Wang F, Shen K, Hatfield K, Enger M, Shafiee S, McCormack E, Ebert BL, Weissleder R, ... ... Parekkadan B, et al. Implantable microenvironments to attract hematopoietic stem/cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 19638-43. PMID 23150542 DOI: 10.1073/Pnas.1208384109  0.774
2012 Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Vellve A, Iracheta-Velle A, Li M, Vitalo A, Parekkadan B, Jindal R, Yarmush ML. Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nature Biotechnology. 30: 179-83. PMID 22252509 DOI: 10.1038/Nbt.2089  0.72
2012 Parekkadan B, Fletcher AL, Li M, Tjota MY, Bellemare-Pelletier A, Milwid JM, Lee JW, Yarmush ML, Turley SJ. Aire controls mesenchymal stem cell-mediated suppression in chronic colitis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 178-86. PMID 21952165 DOI: 10.1038/Mt.2011.192  0.773
2012 Li M, Tilles AW, Milwid JM, Hammad M, Lee J, Yarmush ML, Parekkadan B. Phenotypic and functional characterization of human bone marrow stromal cells in hollow-fibre bioreactors. Journal of Tissue Engineering and Regenerative Medicine. 6: 369-77. PMID 21710576 DOI: 10.1002/Term.439  0.781
2011 Parekkadan B, Upadhyay R, Dunham J, Iwamoto Y, Mizoguchi E, Mizoguchi A, Weissleder R, Yarmush ML. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology. 140: 966-75. PMID 20955701 DOI: 10.1053/J.Gastro.2010.10.013  0.616
2011 Jiao J, Milwid JM, Yarmush ML, Parekkadan B. A mesenchymal stem cell potency assay. Methods in Molecular Biology (Clifton, N.J.). 677: 221-31. PMID 20941614 DOI: 10.1007/978-1-60761-869-0_16  0.79
2010 Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B, Yarmush ML. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1857-64. PMID 20664529 DOI: 10.1038/Mt.2010.155  0.77
2010 Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, Yarmush ML. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplantation. 19: 667-79. PMID 20525442 DOI: 10.3727/096368910X508762  0.604
2010 Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering. 12: 87-117. PMID 20415588 DOI: 10.1146/Annurev-Bioeng-070909-105309  0.79
2009 Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Engineering. Part A. 15: 3377-88. PMID 19397469 DOI: 10.1089/Ten.Tea.2008.0681  0.614
2008 Parekkadan B, Berdichevsky Y, Irimia D, Leeder A, Yarmush G, Toner M, Levine JB, Yarmush ML. Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neuroscience Letters. 438: 190-5. PMID 18467031 DOI: 10.1016/J.Neulet.2008.03.094  0.584
2008 Parekkadan B, Tilles AW, Yarmush ML. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells Stem Cells. 26: 1913-1919. PMID 18420833 DOI: 10.1634/Stemcells.2007-0790  0.602
2008 van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology (Baltimore, Md.). 47: 1634-43. PMID 18395843 DOI: 10.1002/Hep.22236  0.604
2008 Levine JB, Leeder AD, Parekkadan B, Berdichevsky Y, Rauch SL, Smoller JW, Konradi C, Berthiaume F, Yarmush ML. Isolation rearing impairs wound healing and is associated with increased locomotion and decreased immediate early gene expression in the medial prefrontal cortex of juvenile rats. Neuroscience. 151: 589-603. PMID 18063315 DOI: 10.1016/J.Neuroscience.2007.10.014  0.419
2008 van Poll D, Parekkadan B, Borel Rinkes IHM, Tilles AW, Yarmush ML. Mesenchymal Stem Cell Therapy for Protection and Repair of Injured Vital Organs Cellular and Molecular Bioengineering. 1: 42-50. DOI: 10.1007/S12195-008-0001-2  0.603
2007 Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. Plos One. 2: e941. PMID 17895982 DOI: 10.1371/Journal.Pone.0000941  0.628
2007 Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochemical and Biophysical Research Communications. 363: 247-52. PMID 17869217 DOI: 10.1016/J.Bbrc.2007.05.150  0.613
2007 Parekkadan B, Sethu P, van Poll D, Yarmush ML, Toner M. Osmotic selection of human mesenchymal stem/progenitor cells from umbilical cord blood. Tissue Engineering. 13: 2465-73. PMID 17665999 DOI: 10.1089/Ten.2007.0054  0.55
Show low-probability matches.